Tyche Industries Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 987502, "name": "Tyche Industries", "stock_name": "Tyche Industries", "full_name": "Tyche Industries Ltd", "name_url": "stocks-analysis/tyche-industries", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "126.90", "chg": -0.25, "chgp": "-0.2%", "dir": -1, "prev_price": "127.15", "mcapval": "135.00 Cr", "mcap": "Micro Cap", "scripcode": 532384, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 11, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE443B01012", "curr_date": "Jun 25, 03:30 PM", "curr_time": "05:50 AM", "last_traded_at": "Jun 25, 03:30 PM IST", "bse_nse_vol": "8.76 k", "exc_status": "Active", "traded_date": "Jun 25, 2026", "traded_date_str": "2026 06 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tyche-industries-987502-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Tyche Industries Ltd Upgraded to Hold as Technicals Improve Despite Financial Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/tyche-industries-ltd-upgraded-to-hold-as-technicals-improve-despite-financial-challenges-4068465", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TycheIndustries_mojoScore_4068465.png", "date": "2026-06-23 08:55:34", "description": "Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 22 June 2026. This change reflects a nuanced assessment of the company’s technical indicators, valuation, financial trends, and overall quality, signalling cautious optimism amid ongoing operational headwinds." }, { "title": "Tyche Industries Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/tyche-industries-ltd-is-rated-sell-4055978", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TycheIndustries_mojoScore_4055978.png", "date": "2026-06-16 10:10:04", "description": "Tyche Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 3 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 16 June 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Tyche Industries Ltd Upgraded to Sell: Financial and Technical Analysis", "link": "https://www.marketsmojo.com/news/stock-recommendation/tyche-industries-ltd-upgraded-to-sell-financial-and-technical-analysis-4035457", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/TycheIndustries_mojoScore_4035457.png", "date": "2026-06-04 08:28:03", "description": "Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 3 June 2026. This change reflects a nuanced improvement in the company’s financial trend and a shift in technical indicators, despite ongoing challenges in valuation and quality metrics." }, { "title": "Are Tyche Industries Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-tyche-industries-ltd-latest-results-good-or-bad-4023924", "imagepath": "", "date": "2026-05-30 19:52:28", "description": "Tyche Industries Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company reported net sales of ₹16.20 crores, reflecting a significant sequential growth of 53.12% from ₹10.58 crores in the previous quarter. This marks the highest quarterly revenue in the last seven quarters and indicates a recovery in sales compared to the year-ago quarter as well.\n\nHowever, despite this topline growth, the company's profitability faced notable challenges. The net profit for the quarter was ₹1.15 crores, which represents a decline of 36.81% from the previous quarter. More concerning is the operating margin, which fell to -4.07%, marking the lowest performance in seven quarters. This negative operating margin indicates that the company is experiencing severe operational stress, as the earnings quality has deteriorated significantly. The operating profit before depreciation..." }, { "title": "Tyche Industries Gains 6.29%: Technical Shift and Mixed Results Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/tyche-industries-gains-629-technical-shift-and-mixed-results-shape-the-week-4022918", "imagepath": "", "date": "2026-05-30 13:07:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Stock surged 6.76% to Rs.137.40 following technical upgrade</p>\n <p><strong>26 May:</strong> Rating upgraded to Sell from Strong Sell despite weak financials</p>\n <p><strong>29 May:</strong> Mixed quarterly results reported with record sales but margin pressures</p>\n <p><strong>29 May:</strong> Week closes at Rs.136.80, up 6.29% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.128.70</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Clo..." }, { "title": "Tyche Industries Q4 FY26: Profitability Concerns Deepen Despite Revenue Recovery", "link": "https://www.marketsmojo.com/news/result-analysis/tyche-industries-q4-fy26-profitability-concerns-deepen-despite-revenue-recovery-4022111", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TycheIndustries_quaterlyResult_4022111.png", "date": "2026-05-29 11:53:02", "description": "Tyche Industries Ltd., a micro-cap pharmaceutical manufacturer specialising in glucosamine hydrochloride and bulk drug intermediates, reported a challenging quarter for Q4 FY26 (January-March 2026) with net profit of ₹1.15 crores, marking a decline of 36.81% quarter-on-quarter and 22.34% year-on-year. Despite a strong 53.12% sequential revenue recovery to ₹16.20 crores, the company's operating profitability deteriorated sharply, with operating margins turning negative for the first time in recent quarters. The stock, currently trading at ₹138.00 with a market capitalisation of ₹136.00 crores, has gained 3.41% following the results announcement but faces mounting operational headwinds." }, { "title": "Tyche Industries Ltd Reports Mixed Quarterly Results Amid Margin Pressures", "link": "https://www.marketsmojo.com/news/stocks-in-action/tyche-industries-ltd-reports-mixed-quarterly-results-amid-margin-pressures-4020347", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TycheIndustries_fintrenddot_4020347.png", "date": "2026-05-29 11:03:07", "description": "Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reported its quarterly results for March 2026, revealing a nuanced financial performance. While net sales reached a record high of ₹16.20 crores, profitability metrics continued to face headwinds, with operating margins contracting and net profit after tax declining sharply over the past six months." }, { "title": "Tyche Industries Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/tyche-industries-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-financials-4013045", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/TycheIndustries_mojoScore_4013045.png", "date": "2026-05-26 09:05:15", "description": "Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 25 May 2026. This change is primarily driven by a shift in technical indicators, even as the company continues to grapple with deteriorating financial performance and expensive valuation metrics." }, { "title": "Tyche Industries Falls 4.88%: 2 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/tyche-industries-falls-488-2-key-factors-driving-the-weekly-decline-4008313", "imagepath": "", "date": "2026-05-23 14:02:26", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 18:</strong> Valuation shifts amid mixed market performance</p>\n <p><strong>May 19:</strong> Downgrade to Strong Sell due to deteriorating fundamentals and bearish technicals</p>\n <p><strong>May 22:</strong> Week closes at Rs.128.70 (-4.88%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.136.15</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.128.70</div><div class=\"stat-change negative\">-4.88%</div></div>\n <div class=\"st..." } ], "total": 153, "sid": "987502", "stock_news_url": "https://www.marketsmojo.com/news/tyche-industries-987502" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "24-Jun-2026", "details": "The trading window of the Company shall remain closed w.e.f July 1 2026 till the expiry of 48 hours after the declaration of Un-Audited Financial results of the Company for the quarter and three Months ended June 30 2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "31-May-2026", "details": "Newspaper Publication og Audited Financial Results for the 4th Quarter and Year Ended March 31 2026", "source": "BSE" }, { "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance", "datetime": "29-May-2026", "details": "Pursuant to Regulation 24A of SEBI(LODR) Regulations 2015 please find enclosed herewith the Annual Secretarial Compliance Report for the Year ended March 31 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Tyche Industries Ltd has declared <strong>30%</strong> dividend, ex-date: 19 Sep 25", "dt": "2025-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Stock surged 6.76% to Rs.137.40 following technical upgrade

26 May: Rating upgraded to Sell from Strong Sell despite weak financials

29 May: Mixed quarterly results reported with record sales but margin pressures

29 May: Week closes at Rs.136.80, up 6.29% for the week

Week Open

Rs.128.70

Week Clo...

Read full news article

Tyche Industries Q4 FY26: Profitability Concerns Deepen Despite Revenue Recovery

2026-05-29 11:53:02

Tyche Industries Ltd., a micro-cap pharmaceutical manufacturer specialising in glucosamine hydrochloride and bulk drug intermediates, reported a challenging quarter for Q4 FY26 (January-March 2026) with net profit of ₹1.15 crores, marking a decline of 36.81% quarter-on-quarter and 22.34% year-on-year. Despite a strong 53.12% sequential revenue recovery to ₹16.20 crores, the company's operating profitability deteriorated sharply, with operating margins turning negative for the first time in recent quarters. The stock, currently trading at ₹138.00 with a market capitalisation of ₹136.00 crores, has gained 3.41% following the results announcement but faces mounting operational headwinds.

Read full news article

Tyche Industries Ltd Reports Mixed Quarterly Results Amid Margin Pressures

2026-05-29 11:03:07

Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reported its quarterly results for March 2026, revealing a nuanced financial performance. While net sales reached a record high of ₹16.20 crores, profitability metrics continued to face headwinds, with operating margins contracting and net profit after tax declining sharply over the past six months.

Read full news article

Tyche Industries Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials

2026-05-26 09:05:15

Tyche Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 25 May 2026. This change is primarily driven by a shift in technical indicators, even as the company continues to grapple with deteriorating financial performance and expensive valuation metrics.